The QualityStocks Daily Tuesday, August 20th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (CHNUF) +55.43%

StockMarketWatch (CETX) +29.61%

BUYINS.NET (IBIO) +27.14%

The QualityStocks Daily Stock List

Ionix Technology, Inc. (IINX)

Financial Content, MarketWatch, Stockopedia, Wallet Investor, Morningstar, Small Cap Exclusive, Market Exclusive, Wallmine, OTC Markets, Simply Wall St, Stockhouse, Last10k, Dividend Investor and Open Insider reported previously on Ionix Technology, Inc. (IINX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. It is concentrating on becoming the business aggregator that primarily promotes photoelectric display, smart energy and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions.

The Company previously went by the name Cambridge Projects, Inc. It changed its name to Ionix Technology, Inc. in February of 2016. The Company lists on the OTC Markets’ OTCQB.

Ionix Technology has four operating subsidiaries. One is Changchun Fangguan Photoelectric Display Technology Co., Ltd. It specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd. It specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Subsidiary Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices. Moreover, subsidiary Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking.

Ionix Technology has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases. This is to capture the market share of OLED high technology.

Ionix Technology earlier entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd. Changchun Fangguan is a top manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix Technology acquired control of Changchun Fangguan.

Recently, Ionix Technology announced the resignation of Chunde Song from its Board of Directors and the appointments of five new independent Directors, all effective July 31, 2019. With these changes, the Company's Board will expand to nine members in total, five of whom will be independent.

Yesterday, Ionix Technology announced that the Board of Directors adopted corporate governance documents. This includes Audit Committee Charter, Compensation Committee Charter, Nominating and Corporate Governance Committee Charter and Code of Ethics. Furthermore, the Company’s Board established an Audit Committee and a Compensation Committee, effective August 9, 2019, and on August 14, 2019, the Board established a Nominating and Corporate Governance Committee.

Ionix Technology, Inc. (IINX), closed Tuesday's trading session at $1.74, off by 1.1364%, on 2,000 volume with 3 trades. The average volume for the last 3 months is 565 and the stock's 52-week low/high is $1.01999998/$2.75.

chart

Medicenna Therapeutics Corp. (MDNAF)

InvestorX, Penny Stock Hub, Stock Twits, Invest Tribune, The Venture Report, Zacks, Stock Pulse, OTC Markets, Wallet Investor, and PR Newswire reported beforehand on Medicenna Therapeutics Corp. (MDNAF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company listed on the OTC Markets’ OTCQB. It concentrates on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad spectrum of cancers. Medicenna Therapeutics has its corporate headquarters in Toronto, Ontario.

The Company is developing a unique set of tunable Superkines™ that can undergo fusing with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna Therapeutics’ lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the U.S. MDNA55 has been studied in five clinical trials involving 132 patients. This includes 112 adults with rGBM.

MDNA55 has demonstrated compelling efficacy. In addition, it has obtained Fast-Track and Orphan Drug status from the FDA (Food and Drug Administration) and FDA/EMA (European Medicines Agency) respectively. MDNA55 targets Temodar-resistant tumors. Delivery by CED infusion of MDNA55 bypasses the BBB (Blood Brain Barrier). Precision delivery attains high doses without systemic exposure.

Furthermore, Medicenna Therapeutics develops MDNA57 for solid tumors and on-malignant cells of the tumor micro-environment; and MDNA109, an IL-2 agonist to treat cancer immunotherapies. Additionally, Medicenna develops MDNA209, an IL-2 antagonist for autoimmune diseases; and MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis. The Company als9 develops MDNA132, an IL-13 agonist to treat solid tumors, and IL 13Ralpha2 chimeric antigen receptor T cell.

At the end of July, Medicenna Therapeutics announced the selection of MDNA19 (previously, MDNA109-LA1) as its second immuno-oncology clinical candidate for the treatment of cancer. Medicenna expects to commence clinical trials with MDNA19 next year.

Dr. Fahar Merchant , President and Chief Executive Officer of Medicenna Therapeutics, said, "Unlike competing IL-2 programs which are unable to meaningfully stimulate cancer killing immune cells, MDNA19 is designed to dramatically boost the population of immune cells to attack cancer instead of immune cells that protect cancer while maintaining a superior safety profile. We strongly believe that MDNA19 could deliver increased benefits to the patient, expand partnering opportunities and become a core driver of the Company's short and long term success."

For the three months ended June 30, 2019, Medicenna Therapeutics reported a Net Loss of $1,294,634 or $0.05 per share. This is in comparison to a loss of $1,038,217 or $0.04 per share for the three months ended June 30 , 2018. The increase in Net Loss year-over-year was mainly because of a lower reimbursement of expenditures from CPRIT in the present year versus the year ago period.

Medicenna Therapeutics Corp. (MDNAF), closed Tuesday's trading session at $0.8991, off by 0.376731%, on 12,200 volume with 15 trades. The average volume for the last 3 months is 29,900 and the stock's 52-week low/high is $0.505580008/$1.74.

chart

Peloton Minerals Corporation (PMCCF)

Mining Stock Education, TheNewswire, Wallet Investor, Gold Stock Data, Bull Market News, Investing News, StockScores, News to Watch, OTC.Watch, InvestorX, Stockwatch, Dividend Investor, OTC Markets, Insider Tracking, and Stockhouse reported beforehand on Peloton Minerals Corporation (PMCCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Peloton Minerals Corporation, together with its subsidiaries, engages in the acquisition and exploration of mineral properties in the United States and Canada. The Company owns three gold exploration projects in Elko County, Nevada. This includes Independence Valley, which is now under option to Kinross Gold USA. The Company formerly went by the name Montana Gold Mining Company, Inc. It changed its name to Peloton Minerals Corporation in 2016. Incorporated in 2000, Peloton Minerals lists on the OTC Markets Group’s OTCQB.

Peloton Minerals’ core projects are three Carlin style gold projects positioned on the Carlin and Long Canyon Gold Trends in Elko County, Nevada. The Company’s core projects also include one Past Producer gold project in the historic Virginia City Mining District, Montana.

All projects are active this year. Kinross Gold Corp. is a Joint Venture (JV) Partner on one of the Nevada Projects spending up to US $4 million. Frederick Private Equity Corporation is a JV Partner on the Montana project spending up to US $2 million.

Peloton Minerals has the above-mentioned gold project in Montana, now under option to Frederick Private Equity Corporation (Frederick PEC) and African Metals Corporation (AMC). Recently, Peloton reported that Frederick PEC signed an agreement with AMC to fund and accelerate exploration on Peloton’s Silver Bell-St. Lawrence Gold Project in Montana (SBSL). SBSL hosts two past producing gold-silver mines, the Silver Bell Mine on the west and the St. Lawrence Mine on the east. Both of these mines operated in the early 1900s. The St. Lawrence was reactivated and operated in the early 1980s.

AMC has agreed to spend the first US$200,000 in exploration during the first year. SBSL comprises a 390 acre claim package located about 4 miles southwest of Virginia City in Madison County, Montana, and about 50 miles southeast of Butte, Montana.

Recently, Peloton Minerals announced it would be closing the first tranche of a non-brokered private placement with the first tranche being CDN$73,352.90 and consisting of 733,529 units priced at CDN$0.10 per unit. Each unit consists of one common share and one common share purchase warrant exercisable for three years at $0.15. The proceeds of the Private Placement will be used for working capital.

Peloton Minerals Corporation (PMCCF), closed Tuesday's trading session at $0.0596, off by 9.505%, on 26,000 volume with 8 trades. The average volume for the last 3 months is 10,720 and the stock's 52-week low/high is $0.051199998/$0.105999998.

chart

The Flowr Corporation (FLWPF)

NetworkNewsWire, SeriousTraders, New Cannabis Ventures, StockAP, CannabisMarketCap, NIC Investors, CannabisNewsWire, HempWireNews, The Seed Investor, Profit Confidential, Simply Wall St, Investor Ideas, Micro Small Cap, Investing.com, Street Insider, Market Screener, Stockwatch, Market Wire News, Cannabis Daily, Proactive Investors, Wallet Investor, GlobeNewswire, Stockhouse, and TradingView reported earlier on The Flowr Corporation (FLWPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Flowr Corporation, by way of its subsidiaries, holds a cannabis production and sales license granted by Health Canada. The Company builds and operates large-scale, GMP-designed cultivation facilities utilizing its own growing systems. Flowr cultivates in advanced, state-of-the-art facilities, with its cannabis tended to by its team of experts. The Flowr Corporation is headquartered in Toronto, Ontario and the Company has a production facility in Kelowna, British Columbia.

Flowr invests in research and development (R&D). Its focus is on providing premium-quality cannabis that appeals to the adult-use recreational market and addresses specific patient needs in the medicinal market. Flowr builds and operates large-scale purpose-built cultivation facilities that efficiently produce consistent cannabis products. Its Kelowna campus is purpose built to pharmaceutical-grade clean room and GMP compliant standards.

The Company’s team of experts use genetics, breeding, as well as nutrient information to create better, healthier and more resilient plants. To date, its facilities team has designed and built 17 cultivation facilities under the former MMAR/MMPR programs and the present ACMPR program. The Company’s Team has been granted three producers’ licences by Health Canada for MedReleaf, In the Zone (The Cronos Group) and Flowr.

In late July, The Flowr Corporation announced that Holigen Holdings Limited, which Flowr is in the process of acquiring the remaining 80.2 percent interest, subject to regulatory approval, has through its subsidiary RPK Biopharma, Unipessoal Lda, received permission from INFARMED to plant cannabis at the Aljustrel project in Portugal. Flowr also received a Health Canada export permit, which allowed it to make an initial shipment of clones from its Kelowna Campus to Portugal.

In the coming weeks, Flowr expects to deliver a considerably larger shipment of clones, upon receipt of applicable export permits. This will position Aljustrel well for the planned 2019 planting and, ultimately, an expected initial harvest later in 2019, pending final licensing.

Furthermore, The Flowr Corporation announced in late July that it joined the Shoppers Drug Mart medical cannabis verification pilot program that was announced in June at the World Cannabis Congress. The intention of the Pilot Program is to increase transparency, interoperability and product identification within the medical cannabis industry.

For Q2 2019, Flowr produced Gross Revenue of roughly $2.8 million and Net Revenue of roughly $2.2 million. This excludes about $358,000 of design and construction fees from Hawthorne Canada Limited in relation to the construction of the R&D facility on the Kelowna Campus. Flowr had a 61 percent increase in grams sold versus Q1 of 2019, driven by expanded distribution and increased production as cultivation activities ramp up in tandem with construction. Construction of Kelowna 1, the Company’s purpose-built, indoor cultivation facility, is expected to be fully operational in Q4 of 2019.

The Flowr Corporation (FLWPF), closed Tuesday's trading session at $2.25, up 5.6338%, on 168,921 volume with 246 trades. The average volume for the last 3 months is 86,566 and the stock's 52-week low/high is $2.06999993/$6.30000019.

chart

Gran Colombia Gold Corp. (TPRFF)

Metals News, GuruFocus, Micro Small Cap, Mining & Energy, Junior Mining Network, Gold Stock Data, Wallet Investor, The Prospector News, and Resource World reported previously on Gran Colombia Gold Corp. (TPRFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gran Colombia Gold Corp. is a mid-tier gold producer listed on the OTC Markets Group’s OTCQX. Its primary focus is in Colombia where it is presently the largest underground gold and silver producer with a number of mines in operation at its Segovia and Marmato Operations. Currently, Gran Colombia is in the midst of an expansion and modernization project at its high grade, production stage Segovia Operations.

The Company’s focus is on the development of the Segovia Operations and Marmato projects to produce strong cash flows in the short, medium and long term. Gran Colombia produces gold from the Segovia Operations, an area of about 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, positioned approximately 10 km southeast of the Segovia mines.

The Marmato Project contains total estimated resources of about 8 million ounces of gold and close to 38 million ounces of silver situated in the Caldas department in the heart of the Middle Cauca gold district. The Marmato Project has first-class infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. It has access to the national electricity grid which runs near the property.

In addition, Gran Colombia Gold has its Zancudo Project. The Zancudo Project is in the Titiribí mining district of Antioquia. The Project comprises an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt, which produced roughly 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.

Last week, Gran Colombia Gold announced the final assay results from 115 diamond drill holes (10,783 meters) included in the 2019 underground infill drilling program at its high-grade Segovia Operations. It also announced the assay results from nine kick-off holes (2,527 meters) in the continuing directional drilling program in the deep zone at the El Silencio mine.

Serafino Iacono, Executive Chairman of Gran Colombia, said, “We are excited to see a continuation of the high grade gold and silver intercepts in the assay results from our ongoing drilling campaign at the Segovia Operations in the first half of 2019. In-fill drilling at each of our three core producing mines increases our confidence in the potential to add new mineral reserves and extend mine life at our flagship mining operation. The deep zone drilling at El Silencio has generated some very encouraging high grade results so far and we expect to complete the first phase of this drilling program by the end of this year.”

In addition, last week, Gran Colombia Gold announced the release of its unaudited interim condensed consolidated financial statements and accompanying management’s discussion and analysis (MD&A) for the three and six months ended June 30, 2019. Revenue amounted to $77.6 million in Q2 of 2019, up 13 percent over Q2 last year. This brings the Total Revenue for the first half of 2019 to $155.1 million. This represents an increase of 16 percent over the first half last year.

All-In Sustaining Costs (AISC) and All-In Costs in Q2 of 2019 were $878 per ounce and $903 per ounce, respectively, both down from $930 per ounce and $937 per ounce, respectively, in Q2 last year. Net Cash Provided by Operating Activities in Q2 of 2019 of $18.2 million brought the total for the first half of 2019 to $38.0 million. This is up 7 percent over the first half last year.

Gran Colombia Gold Corp. (TPRFF), closed Tuesday's trading session at $4.2108, up 3.3706%, on 17,798 volume with 23 trades. The average volume for the last 3 months is 32,106 and the stock's 52-week low/high is $1.58819997/$4.39989995.

chart

MediPharm Labs Corp. (MEDIF)

Midas Letter, The Cannabis Investor, Investing News, Insider Financial, Stockhouse, Micro Small Cap, InvestorsHub, CannabisFN, Small Cap Power, Profit Confidential, TradingView, TMXmoney, and Street Register reported earlier on MediPharm Labs Corp. (MEDIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MediPharm Labs Corp. is a worldwide leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation. It is the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation licence. MediPharm principally focuses on producing pharma-grade cannabis oil and concentrates in Canada. MediPharm Labs has its corporate office in Barrie, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQX.

MediPharm Labs is an international leader in premier quality, industrial-scale cannabinoid-based derivatives. It also focuses on providing cannabis contract processing services to licensed producers and growers; supplying cannabis oil to companies for sale under its brand; and supplying raw materials and processing for the creation of market ready cannabis products. Its cannabis extraction services meet the global quality standards of the cannabis Industry by supplying purified cannabis concentrates.

MediPharm has invested in an expert, research-driven team, state-of-the-art technology, downstream extraction methodologies and purpose-built facilities to deliver pure, safe and precisely-dosed cannabis products to patients and consumers. The Company’s private label program is a high margin business. It procures dry cannabis flower and trim from its many product supply partners to produce cannabis oil concentrate products for resale globally on a private label basis.

Last week, MediPharm Labs announced its financial results for the three and six months ended June 30, 2019, including strong growth in Revenue, EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), Net Income and Earnings Per Share. Revenue was $31.5 million. This represents a 43 percent increase over Q1 2019.

Adjusted EBITDA was $7.7 million, 79 percent higher than Q1 2019. Adjusted EBITDA margin was 24 percent versus 20 percent in Q1 2019. Net Income Before Tax was $4.1 million versus a Net Loss of $0.3 million in Q1 2019.

Today, MediPharm Labs announced that it appointed renowned patient care and medical cannabis researcher, Dr. Carolina Landolt-Marticorena, MD, PhD, Structural Biochemistry, to its Science Advisory Committee (SAC). Dr. Landolt-Marticorena also serves on the Cannabis Medical Advisory Board of Shoppers Drugmart. Dr. Landolt-Marticorena is trained in internal medicine and rheumatology. She has a sub-specialization in the management of complex autoimmune disorders.

MediPharm Labs Corp. (MEDIF), closed Tuesday's trading session at $4.148, off by 4.2254%, on 204,306 volume with 417 trades. The average volume for the last 3 months is 262,257 and the stock's 52-week low/high is $0.912500023/$5.65000009.

chart

Applied Biosciences Corp. (APPB)

InvestorsHub, MarketWatch, Wallet Investor, Uptick Newswire, GuruFocus, Investors Hangout, Dividend Investor, Daily Marijuana Observer, Talk Markets, Corporate Information, Barchart, Trading View, Accesswire, Small Cap Podcast, The Street, and Stockhouse reported earlier on Applied Biosciences Corp. (APPB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Applied Biosciences Corp. is a diversified cannabinoid therapeutics company. Its focus is on the medical, bioceutical, testing and pet health industries. The Company’s emphasis is on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and pet industries. Applied Biosciences has its corporate office in Beverly Hills, California.

Applied Biosciences is a leading company in the CBD and Pet health space. It is currently shipping to the majority of U.S. States and also to numerous international countries. The Company has a number of strategic partnerships now in place. It is pursuing additional partnerships and other strategic growth opportunities.

Applied Biosciences’ products include Remedi and Herbal Pet. The team at Remedi, based in Colorado, is a collaboration project of hemp and CBD industry professionals. Remedi has launched an initial line of hemp CBD infused products centered on delivery methods with proven and noticeable effects.

Herbal Pet’s focus is a new standard of care in pet health. Its product can provide safe, natural, veterinarian-recommended products directly to owners. Herbal Pet delivers premier quality cannabinoid-based nutraceuticals for cats and dogs.

Applied Biosciences has announced it signed a partnership agreement with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first round knockouts. Via this new partnership, Shannon Briggs and Applied Biosciences will work together to formulate a line of athlete-focused cannabidiol (CBD) based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.

Recently, Applied Biosciences announced it retained the Emmes Group to assist with the development and execution of the Company's partnership and technology licensing initiatives and strategies. By way of the new partnership, Emmes and Applied Biosciences will work together to formulate a line of medical and scientific focused cannabidiol (CBD) based products to target the endocannabinoid system under the "Applied BioPharma" brand.

Applied Biosciences Corp. (APPB), closed Tuesday's trading session at $0.7475, up 35.9091%, on 168 volume with 3 trades. The average volume for the last 3 months is 262,257 and the stock's 52-week low/high is $0.479999989/$2.95000004.

chart

American Rebel Holdings, Inc. (AREB)

Wallet Investor, Market Screener, OTC Markets, Stockwatch, Trading View, Dividend Investor, Penny Stock Hub, Capital Cube, Investors Hangout, Stocks News Feed, Street Insider, Simply Wall St, Morningstar, 4-Traders, Barchart, Wallmine, and MarketWatch reported previously on American Rebel Holdings, Inc. (AREB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

American Rebel Holdings, Inc. is positioning itself as America's Patriotic Brand. It engages in developing diverse products in the self-defense and patriotic product areas. The Company centers on designing, manufacturing, and marketing concealed carry backpacks under the American Rebel brand name. Mr. Charles A. "Andy" Ross founded the Company as America's Patriotic Brand. American Rebel Holdings has its corporate headquarters in Nashville, Tennessee. The Company lists on the OTC Markets’ OTCQB.

American Rebel’s first product offering is its line of concealed carry products. These were launched at the 2017 NRA (National Rifle Association) Annual Meeting. The design of the Company’s products is to give one the tools needed to defend and protect oneself, their family and more. The Cartwright Concealed Carry Coat by American Rebel is featured in the third installment of a five-part series in the NRA Publication America's 1st Freedom on how to choose the proper handgun to carry for defensive purposes.

This year, American Rebel Holdings is expanding its product offerings to include Large Floor Gun Safes, Wall Safes, as well as Personal Safes. Mr. Andy Ross, American Rebel Chief Executive Officer (CEO), said, "American Rebel products keep you concealed and safe inside and outside the home."

American Rebel Safes will protect one’s firearms and valuables from theft, fire, natural disasters and in a place only appropriate members of the household can access. Mr. Nathan Findley, who comes to American Rebel Holdings with more than 10 years' experience in the outdoor and firearms industries, will lead American Rebel's expansion in gun safes.

Recently, American Rebel reported sales four times greater than 2018 at the NRA Great American Outdoor Show in Harrisburg, Pennsylvania from February 2-10, 2019. The Company said that the Cartwright Concealed Carry Coats and Cartwright Concealed Carry Backpacks were the top sellers during the trade show. These were followed by the Men's Freedom Jackets. American Rebel CEO Mr. Andy Ross appeared on a recent edition of MoneyTV to report the strong results.

American Rebel Holdings, Inc. (AREB), closed Tuesday's trading session at $0.718, up 30.5455%, on 1,275 volume with 2 trades. The average volume for the last 3 months is 815 and the stock's 52-week low/high is $0.150000005/$1.25.

chart

Canarc Resource Corp. (CRCUF)

ShazamStocks, CrushTheStreet, Baby Bulls, FeedBlitz, All Penny Stocks, Research Driven Investor, Future Money Trends, SmallCapVoice, and Stockhouse reported earlier on Canarc Resource Corp. (CRCUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Canarc Resource Corp. is a growth-oriented, gold exploration and mining company listed on the OTCQB. It is currently focusing on advanced Gold and Silver assets located in North America. Canarc Resource has its corporate headquarters in Vancouver, British Columbia. 

The Company’s core Gold Project asset is the 100 percent owned, past-producing, high-grade New Polaris gold mine project in northwestern British Columbia. Based on an updated NI (National Instrument) 43-101 resource estimate using a 6 gpt gold cutoff grade, the New Polaris property presently contains measured and indicated resources of 519,000 oz gold contained in 1,288,000 tonnes grading 12.5 gpt gold.

New Polaris is the Company’s most advanced gold mine project. New Polaris contains inferred resources totaling 636,000 oz gold contained in 1,628,000 tonnes grading 12.2 gpt gold. It is still open for expansion in other veins and at depth.

Canarc Resource also has its Windfall Hills gold project.  Windfall Hills is 65 kilometers south of Burns Lake and 90 kilometers northwest of Richfield Ventures’ Blackwater gold discovery in central British Columbia. The Windfall Hills project covers claims totaling 3879 hectares. The Company’s Projects also include Corral Canyon, Hard Cash and Nigel, and The Princeton Gold Property.

Recently, Canarc Resource announced the completion of a 970 line-km airborne magnetic and radiometric survey over the newly acquired 2,090 hectare Hard Cash Gold Property in southwestern Nunavut, Canada. Recently, Canarc Resource entered into an option agreement with Silver Range Resources to acquire a 100 percent interest in Hard Cash. Nunavut is home to two multi-million ounce gold deposits at the operating Meadowbank Mine and the Meliadine Mine now under construction, both owned by Agnico Eagle Mines.

Mr. Scott Eldridge, Canarc Resource Chief Executive Officer, stated: ''Since identifying Hard Cash late last year as a district scale gold exploration opportunity, Canarc has visited the site, sampled high grade gold in bedrock, signed an option agreement to acquire a 100% interest, completed an aero-geophysical survey, and we plan to drill the initial high priority targets this summer. We are moving expeditiously to execute our new corporate strategy of acquiring and exploring high impact gold discovery projects and de-risking our current core assets in order to create shareholder value.''

Canarc Resource Corp. (CRCUF), closed Tuesday's trading session at $0.0612, up 22.4%, on 64,000 volume with 10 trades. The average volume for the last 3 months is 815 and the stock's 52-week low/high is $0.0239/$0.061799999.

chart

Alltemp, Inc. (LTMP)

MissionIR, Stock Communications Group, Dividend Investor, 4-Traders, InvestorsHub, GuruFocus, The Street, Investors Hangout, Barchart, StockInvest, MarketWatch, Stockhouse, Morningstar, Wallet Investor, Market Screener, and Capital Cube reported earlier on Alltemp, Inc. (LTMP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alltemp, Inc. is a developer of proprietary, environmentally-friendly, refrigerant technologies. The Company has developed a proprietary refrigerant technology, called alltemp®. This is a proven replacement for many global refrigerants that have adversely affected the worldwide environment.  Alltemp is based in Westlake Village, California.

alltemp®’s refrigerants are for the commercial and residential markets. alltemp® is the Company’s solution for the replacement of R-407c, R-134a, R-404a, and HCFC-22, known as R-22, but which is quickly being phased out in all developed nations because of environmental concerns over its strong effect on the depletion of the Earth's ozone layer.  

alltemp® refrigerants have broad applications. These range from Heating Ventilation and Air Conditioning (HVAC), to refrigeration and foam insulation, to industrial solvents. alltemp® solutions provide a sustainable, eco-friendly, true drop-in refrigerant. It meets the Montreal/Kyoto Protocols and EPA  (Environmental Protection Agency) standards with the lowest Global Warming Potential for any non-flammable HFC. alltemp®  yields a 27 percent average decrease in kWh,  without loss in capacity.

Alltemp successfully completed two years of early adopter testing of its alltemp® refrigerant at several Fortune 100 companies' facilities for its Montreal and Kyoto Protocol compliant refrigerant. Furthermore, test results revealed that alltemp® yielded significant average savings in energy consumption. This is while maintaining capacity.

Alltemp announced in January 2018 that it released a new refrigerant alternative for R-404A applications called alltemp® 4. This is a drop-in refrigerant. R-404A has one of the highest GWPs (Global Warming Potential) of any HFC refrigerants. It is quickly being phased out in the European Union (EU) and other developed countries.

Alltemp announced in March 2018 that flashpoint chamber testing conducted by DEKRA Insight confirmed that alltemp® refrigerant has zero flammability. A minimum of 20 different chamber tests in the liquid phase and 20 vapor phase tests, with temperatures as high as 60º C = 140º F, revealed zero flammability and no ignition with alltemp® refrigerant.

Alltemp has its R-410A replacement refrigerant, designated alltemp® H. Like the Company’s other refrigerants, alltemp® H is engineered to use the same anti-corrosive and non-flammable alltemp® core technology that provides major energy efficiencies and meets ASHRAE A1 safety classification standards.

R-410A was designed to replace R-22, which has a substantial environmental impact and Ozone Depletion Potential (ODP). The lower the GWP value, the better the refrigerant is for the environment. R-410A has a Global Warming Potential (GWP) rating of 2,088. Its predecessor R-22 has a GWP rating of 1700.

Alltemp, Inc. (LTMP), closed Tuesday's trading session at $0.0579, up 44.75%, on 26,479 volume with 6 trades. The average volume for the last 3 months is 84,130 and the stock's 52-week low/high is $0.029999999/$0.172499999.

chart

Esports Entertainment Group, Inc.  (GMBL)

Stockrow, Real Pennies, Dividend Investor, Proactive Investors, Capital Network, Infront Analytics, YCharts, OTC Markets, RedChip, Marketbeat, TradingView, Capital Cube, and Wallet Investor reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business especially focused on esports wagering. Its plan is to offer wagering on esports events in a fully licensed, regulated, and secured platform to the global esports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua, and Barbuda.

Esports Entertainment Group previously announced the hiring of two key executives and the opening of its new international headquarters in Malta. Malta was selected because of its strategic location within the European Union (EU), and also access to a highly educated and multi-lingual workforce, particularly in the fields of online gambling.

The Company’s plan is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.  

Esports Entertainment is a licensed online gambling business with a particular emphasis on esports wagering and 18+ gaming. The Company’s online esports gambling platform will be completely licensed and the highest regulated esports gambling site worldwide.

The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from centers in Canada and Antigua.

Esports Entertainment has an agreement with PartnerMatrix. This is the first platform that enables online sportsbook and casino operators to run Affiliate System with Agent functionality and Agent System with Affiliate functionality. With the agreement, Esports Entertainment Group will integrate the PartnerMatrix platform to manage its affiliate program on an expedited basis. Esports Entertainment Group has also launched vie.gg. This is the world’s first and most transparent esports betting exchange.

Recently, Esports Entertainment Group announced Affiliate Marketing Agreements with 14 more esports teams as it continues to ramp up affiliate marketing activities in support of its launch of vie.gg. The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5, 2018.

Esports Entertainment Group, Inc. (GMBL), closed Tuesday's trading session at $0.488, up 26.4249%, on 1,525 volume with 3 trades. The average volume for the last 3 months is 19,426 and the stock's 52-week low/high is $0.263999998/$0.973999977.

chart

First Foods Group, Inc. (FIFG)

Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.

First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.

First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities.

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.

First Foods Group, Inc. (FIFG), closed Tuesday's trading session at $0.5, up 24.9688%, on 22,299 volume with 10 trades. The average volume for the last 3 months is 9,111 and the stock's 52-week low/high is $0.050999999/$0.600000023.

chart

Inspyr Therapeutics, Inc. (NSPX)

BUYINS.NET and Zacks reported earlier on Inspyr Therapeutics, Inc. (NSPX), and today we report on the Company, here at the QualityStocks Daily Newsletter.  

Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company based in Westlake Village, California. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is its lead agent. Mipsagargin is in human clinical trials for patients’ with numerous different tumor types. Inspyr Therapeutics’ team has considerable pharmaceutical industry and scientific experience.

The Company lists on the OTC Markets Group’s OTCQB. It previously went by the name GenSpera, Inc. It changed its name to Inspyr Therapeutics, Inc. in August of 2016.  

Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer. Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer). It has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication.  

Mipsagargin is now undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). In addition, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.  

Inspyr Therapeutics has started the second development program for Mipsagargin as part of a combination therapeutic approach. This new program centers on the treatment of gastric cancer.

Inspyr has started a preclinical study in gastric cancer PDX tumor models that express varying levels of PSMA, the target of Mipsagargin. In this initial study, Mipsagargin will undergo evaluation initially in combination with paclitaxel.   

Inspyr Therapeutics is developing a novel technology platform. This platform combines a strong therapeutic (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. This unique platform technology has the potential to work across a range of drugs that precisely target different cancers.       

In October of 2017, Inspyr Therapeutics announced the start of a new investigator-sponsored preclinical study of its proprietary adenosine receptor modulator (ARM) based compounds. The preclinical study is led by Elizabeth Kang, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This study will assess these compounds for the prevention of graft versus host disease (GvHD), a potential side effect of allogeneic stem cell transplants.

Inspyr Therapeutics, Inc. (NSPX), closed Tuesday's trading session at $0.00459, up 20.7895%, on 418,173 volume with 9 trades. The average volume for the last 3 months is 465,990 and the stock's 52-week low/high is $0.002199999/$0.01305.

chart

China Education Resources, Inc. (CHNUF)

Marketwired, OTC Markets, Barchart, Stockhouse, MarketWatch, Business Insider, Wall Street Reporter, and Stockwatch reported on China Education Resources, Inc. (CHNUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, China Education Resources, Inc. is an ed-tech company. It has leading technology of intelligent systems and contents to provide online/offline learning, training courses, and social media for teachers, students and education professionals. China Education Resources has its headquarters in Vancouver, British Columbia.

The Company, by way of its subsidiaries in China, is a foremost provider of kindergarten to grade 12 (K-12) education resources and services. This is through its national internet site to China's kindergarten to grade 12 education market.

In addition, the Company has developed soccer education textbooks and a training/learning online platform to provide an innovative blend of online/offline contents and services to teachers and students for soccer education programs. The soccer textbooks include 13 student soccer textbooks (one book per grade) and four teacher’s books for teaching the student soccer textbooks. Additionally, the soccer textbooks have soccer training video contents for students and teachers.

China Education Resources is working on an indoor kids’ soccer training program. The Company has rented a 2,900 square foot space in a shopping mall to commence its indoor kids’ soccer training program. The program will offer face to face soccer training together with the Company’s online soccer training platform with video contents and online/offline interaction among students, coaches and parents.

China Education Resources’ online teacher training program has expanded into another four new provinces in China. The Company was recently selected by the Ministry of Education, China to provide vocational teacher training programs. The vocational online training platform has been developed by China Education Resources together with an initial 185 training courses.

Recently, China Education Resources provided an update on its business development. The Company signed a Memorandum of Understanding (MOU) with World Book, Inc. World Book is part of Berkshire Hathaway and the publisher of the renowned World Book Encyclopedia.

The two parties are discussing cooperation opportunities in certain areas. This includes partnering together to create custom contents around China Education Resources’ programs; distribution of World Book’s books and digital products in English to schools and libraries in China; licensing and translating into Chinese World Book’s titles and selling the books in China; book club with the direct to consumer model, and more.

China Education Resources, Inc. (CHNUF), closed Tuesday's trading session at $0.0429, up 55.4348%, on 56,600 volume with 3 trades. The average volume for the last 3 months is 3,390 and the stock's 52-week low/high is $0.0193/$0.049800001.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto Stock Exchange (“TSX”). The company’s common shares will start trading on the TSX when the market opens on Thursday, August 22, 2019, under the symbol ‘OGI’. In order to ensure continuous trading for the company’s shareholders during the uplisting, Organigram’s shares will be delisted from the TSX Venture Exchange (“TSX.V”) at the beginning of trading on the TSX. To view the full press release, visit: http://nnw.fm/FsA8s.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $5.13, up 2.1912%, on 585,200 volume with 2,239 trades. The average volume for the last 3 months is 1,060,646 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular, augmented reality, interactive, entertainment games and toys in China, is well positioned in a market that is anticipated to see continuous growth in the coming years.

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Tuesday's trading session at $2.82, up 0.714286%, on 123,527 volume with 405 trades. The average volume for the last 3 months is 238,870 and the stock's 52-week low/high is $2.71000003/$6.25.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) entered into an exclusive partnership with PAX Labs in June (http://nnw.fm/0Zs3T). To view the full article, visit: http://nnw.fm/l3Kdt. Also today, NetworkNewsWire released a report on the company detailing how SPRWF is well positioned as the global cannabis markets have been experiencing a rapid growth rate in the last few years and they are projected to rise even faster and further in the coming years. Sometimes, though, it’s hard to get the experts agree to the numbers… BUT they do all agree that revenues will continue to rise. For example, a report from Green Entrepreneur forecasts $40 billion sales in the global cannabis markets by 2024.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $1.28, up 8.4746%, on 1,266,319 volume with 993 trades. The average volume for the last 3 months is 370,900 and the stock's 52-week low/high is $0.850000023/$2.03999996.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTCQB: ETST), together with its wholly owned subsidiaries, is working to advance its role as a leader in the global CBD sector. To view the full article, visit: http://nnw.fm/R08bN.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.78, up 2.6316%, on 148,537 volume with 56 trades. The average volume for the last 3 months is 62,240 and the stock's 52-week low/high is $0.300999999/$2.45000004.

Recent News

chart

MustGrow Biologics Corp. (CSE: MGRO)

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics Corp. (CSE: MGRO) was featured today in the 420 with CNW by CannabisNewsWire. Y-Combinator, a startup accelerator based in California, has picked interest in an Ontario-based startup which is developing a breathalyzer that can detect both alcohol and marijuana on the breath of drivers. Y-Combinator is known for having worked with Airbnb, Dropbox and Reddit, so the Canadian startup should be given ample attention if it has caught the eye of this startup accelerator.

MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

MustGrow Biologics Corp. (CSE: MGRO), closed Tuesday's trading session at $0.31, up 3.33%, on 45,000 volume with 5 trades. The average volume for the last 3 months is 65,231 and the stock's 52-week low/high is $0.25/$0.699999988.

Recent News

chart

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: NABIF).

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the appointment of cannabis industry veteran Emmanuel Paul to its board of directors, effective August 16, 2019. To view the full press release, visit: http://nnw.fm/p5CK6. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. SannTek Labs Inc. is the company behind the breathalyzer. This company was founded by two engineering graduate students at the University of Waterloo. The duo plan to develop a testing device which is more robust, more accurate and less invasive than what is currently available on the market. The current THC testing equipment on the market requires a saliva or blood sample.

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: NABIF), closed Tuesday's trading session at $0.1477, up 0.963839%, on 35,766 volume with 14 trades. The average volume for the last 3 months is 51,432 and the stock's 52-week low/high is $0.119249999/$0.791499972.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions, Inc. (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, has engaged investor relations specialists MZ Group (MZ) to lead a comprehensive strategic investor relations and financial communications program across all key markets.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Tuesday's trading session at $0.05736, up 4.2909%, on 983 volume with 3 trades. The average volume for the last 3 months is 122,203 and the stock's 52-week low/high is $0.032000001/$2.5999999.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

Innovative technology holding company VPR Brands LP (OTC: VPRB) recently posted financial results for the first quarter 2019, highlighting increased revenues and a reduced net loss as compared to 2018. To view the full article, visit: http://nnw.fm/yYvh0.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Tuesday's trading session at $0.07, even for the day, on 25,657 volume with 6 trades. The average volume for the last 3 months is 59,187 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Many consumers don’t realize that they don’t need to smoke to partake of nicotine. In fact, new advancements are providing an alternative to the risks associated with smoking, which were first officially revealed by a damning surgeon general report in 1963 linking smoking to lung cancer, emphysema and heart disease. Case in point, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed technology that offers an alternative method of nicotine ingestion that is safer than smoking, and the company hopes to change the world for the better by eliminating the diseases caused by combusting tobacco. Also today, NetworkNewsWire released a report on the company detailing how LXRP is increasing the reach of its revolutionary DehydraTECH(TM) technology that enables the rapid onset of ingested cannabis. To view the full article, visit: http://nnw.fm/X99Ha

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.77, off by 5.5215%, on 62,082 volume with 141 trades. The average volume for the last 3 months is 72,714 and the stock's 52-week low/high is $0.600000023/$2.24.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Global developer and provider of cellular communications systems Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) today announced a non-brokered private placement to raise $3.0M consisting of 7.5 million units, each at a price of $.40, with one strategic investor. To view the full press release, visit: http://nnw.fm/t6V3B

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Tuesday's trading session at $0.3279, off by 7.6338%, on 10,6675 volume with 30 trades. The average volume for the last 3 months is 54,888 and the stock's 52-week low/high is $0.288599997/$0.446249991.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is revolutionizing the heavy oil recovery process through its clean, closed-loop technology that’s capable of extracting fuel from sands and returning the cleaned sands back to the earth.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Tuesday's trading session at $0.1822, off by 2.8267%, on 147,800 volume with 36 trades. The average volume for the last 3 months is 228,321 and the stock's 52-week low/high is $0.127000004/$1.27499997.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB: SING) President Wil Ralston said on MoneyTV that SING is growing in several directions. During an interview with host Donald Baillargeon (http://nnw.fm/T4jH4), Ralston projected that the company’s solar division will generate some $5 million in revenues this year as it continues to increase residential sales and adds commercial sales while also providing funding options for small to medium businesses on renewable projects.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0132, off by 0.75188%, on 3,862,819 volume with 76 trades. The average volume for the last 3 months is 5,676,025 and the stock's 52-week low/high is $0.009999999/$0.041000001.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Tuesday's trading session at $1.55, up 17.4242%, on 196,010 volume with 684 trades. The average volume for the last 3 months is 511,040 and the stock's 52-week low/high is $0.697000026/$3.16000008.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Tuesday's trading session at $1.39, up 11.2%, on 43,130 volume with 52 trades. The average volume for the last 3 months is 18,315 and the stock's 52-week low/high is $0.100100003/$1.80999994.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.